Assessment of Biochemical Oxidative Stress Markers in Patients with Psoriasis
International Journal of Pharmaceutical Quality Assurance · 10.07.2026 · 16 (11)
DOI: 10.25258/ijpqa.16.11.115 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 10.07.2026. Verfasst von Abhishek Ranjan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Psoriasis is a chronic immune-mediated inflammatory disorder increasingly recognized as a systemic disease associated with oxidative stress and metabolic abnormalities.
Aim
To assess biochemical oxidative stress markers in patients with psoriasis and evaluate their association with disease severity. Methodology: This hospital-based case–control study included 90 participants (45 psoriasis patients and 45 ageand sex-matched healthy controls). Fasting blood samples were analyzed for routine biochemical parameters and oxidative stress markers, including malondialdehyde (MDA), advanced oxidation protein products (AOPP), and catalase. Disease severity was assessed using the Psoriasis Area and Severity Index (PASI). Statistical analysis was performed using SPSS version 27.0.
Results
Psoriasis patients showed significantly higher levels of MDA, AOPP, CRP, fasting glucose, total cholesterol, triglycerides, and LDL, with lower HDL and catalase levels (p
Zitieren
APA
Ranjan, A., Satyam, S., & Zahedi, A. A. (2026). Assessment of Biochemical Oxidative Stress Markers in Patients with Psoriasis. International Journal of Pharmaceutical Quality Assurance, 16(11). https://doi.org/10.25258/ijpqa.16.11.115
Vancouver
Ranjan A, Satyam S, Zahedi AA. Assessment of Biochemical Oxidative Stress Markers in Patients with Psoriasis. International Journal of Pharmaceutical Quality Assurance. 2026;16(11). doi:10.25258/ijpqa.16.11.115
BibTeX
@article{Ranjan2026,
author = {Ranjan, Abhishek and Satyam, Satyam and Zahedi, Asfi Ahmad},
title = {Assessment of Biochemical Oxidative Stress Markers in Patients with Psoriasis},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {11},
doi = {10.25258/ijpqa.16.11.115}
}
EUVIMED